AMBER WEBB: Open Payments
NPI 1962980268 · SHERIDAN, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 22 payments from 12 companies in 2025. Trend: 2023 $360 · 2024 $384 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $105 |
| ABBVIE INC. | 4 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Novo Nordisk Inc | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Globus Medical, Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Antares Pharma, Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| PFIZER INC. | 1 | $16 |
Products named: AIRSUPRA, CAPLYTA, UBRELVY, QULIPTA, HETLIOZ, Senza, GEMTESA, BREZTRI.
Industry payments across AR — which companies pay providers there.
